Oscar Health, Inc. (OSCR) is a Medical - Healthcare Plans company in the Healthcare sector, currently trading at $15.29. It has a SharesGrow Score of 40/100, indicating a mixed investment profile with 1 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of OSCR = $3,319.89 (+21612.8% from the current price, the stock appears undervalued). Analyst consensus target is OSCR = $17 (+11.2% upside).
Valuation: OSCR trades at a trailing Price-to-Earnings (P/E) of -9.2 (S&P 500 average ~25).
Financials: revenue is $11.7B, +42%/yr average growth. Net income is $443M (loss), growing at -559.3%/yr. Net profit margin is -3.8% (negative). Gross margin is 14.4% (-85.6 pp trend).
Balance sheet: total debt is $430M against $978M equity (Debt-to-Equity (D/E) ratio 0.44, conservative). Current ratio is 0.95 (tight liquidity). Debt-to-assets is 6.8%. Total assets: $6.3B.
Analyst outlook: 2 / 10 analysts rate OSCR as buy (20%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 78/100 (Pass), Growth 58/100 (Partial), Past 25/100 (Fail), Health 33/100 (Fail), Moat 35/100 (Fail), Future 40/100 (Partial), Income 10/100 (Fail).
